Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03635528 · ClinicalTrials.gov registry record · NA
Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03635528: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT03635528 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03635528, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This is a bilateral, non-dispensing, randomized, controlled, double-masked, 7x7 cross-over study. Each subject will be bilaterally fitted with one of the 7 test articles in each of the 7 periods for a total of four visits. Up to two lens types will be fit at each of the four study visits.
Primary Outcome
On-axis accommodative response with target vergence of 0.25D, 1D, 2D, 3D and 4D measured with a wavefront aberrometer.
Interventions
- DEVICE Test Lens 1
- DEVICE Test Lens 2
- DEVICE Test Lens 3
- DEVICE Test Lens 4
- DEVICE Test Lens 5
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-11-29 |
| Est. Completion | 2019-07-18 |
| Phase | NA |
What the finished NCT03635528 record still lists
NCT03635528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Test Lens 1 is the first listed.
NCT03635528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03635528 about?
NCT03635528 is a clinical study titled "Evaluating Accommodative Responses of Soft Contact Lenses for Myopia Control". This is a bilateral, non-dispensing, randomized, controlled, double-masked, 7x7 cross-over study. Each subject will be bilaterally fitted with one of the 7 test articles in each of the 7 periods for a total of four visits. Up to two lens types will be fit at each of the four study visits.
What is the current status of trial NCT03635528?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-11-29. Estimated completion is 2019-07-18.
What interventions are being tested in trial NCT03635528?
The interventions under investigation include: Test Lens 1 (DEVICE), Test Lens 2 (DEVICE), Test Lens 3 (DEVICE), Test Lens 4 (DEVICE), Test Lens 5 (DEVICE).
Who is sponsoring clinical trial NCT03635528?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03635528's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI